摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-hydroxybenzylglycol ether

中文名称
——
中文别名
——
英文名称
4-hydroxybenzylglycol ether
英文别名
4-((2-hydroxyethoxy)methyl)phenol;4-[(2-Hydroxyethoxy)methyl]phenol;4-(2-hydroxyethoxymethyl)phenol
4-hydroxybenzylglycol ether化学式
CAS
——
化学式
C9H12O3
mdl
——
分子量
168.192
InChiKey
NZKSMKXYYTXWMA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    4-hydroxybenzylglycol ether 、 3-bromo-6-(tetrahydro-2H-pyran-2-yl)-6H-thieno[2,3-e]-indazole-1,1-dioxide 在 caesium carbonate 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 以81%的产率得到3-(4-((2-hydroxyethoxy)methyl)phenoxy)-6-(tetrahydro-2H-pyran-2-yl)-6H-thieno[2,3-e]indazole-1,1-dioxide
    参考文献:
    名称:
    噻吩并[2,3-e]吲唑衍生物作为新型口服选择性雌激素受体降解剂的发现,具有高度改善的抗肿瘤作用和良好的成药性
    摘要:
    内分泌治疗在早期和转移性雌激素受体 α 阳性 (ERα+) 乳腺癌 (BC) 的治疗中受到新发耐药和获得性耐药的极大限制。由于独特的机制,选择性雌激素受体降解剂 (SERD) (如氟维司群)为内分泌治疗组合提供了新策略。在此,我们通过用 6 H-噻吩并[2,3 - e ]吲唑代替 6-羟基苯并噻吩,公开了基于结构的 LSZ102 优化。随后的丙烯酸 degron 修饰使我们将化合物40确定为首选候选者。一般来说,化合物40显示出比先导 LSZ102 更好的药理学特征,表现出对野生型或他莫昔芬抗性 MCF-7 细胞的生长抑制,有效的 ERα 降解,以及优越的药代动力学特性,包括大脑在内的定向靶组织分布,以及强大的抗肿瘤功效小鼠乳腺癌异种移植模型。目前,40 个正在临床前试验中进行评估。
    DOI:
    10.1021/acs.jmedchem.2c00008
  • 作为产物:
    描述:
    对甲酚氧气乙二醇 、 sodium hydroxide 作用下, 反应 18.0h, 生成 对羟基苯甲醇4-hydroxybenzylglycol ether对羟基苯甲醛
    参考文献:
    名称:
    Practical Process for the Air Oxidation of Cresols:  Part B. Evaluation of the Laboratory-Scale Oxidation Process
    摘要:
    Mechanistic proposals and predictions made in a preceding paper (Part A) were evaluated by carrying out the catalytic air oxidation of p-cresol in an alternative solvent system, comprising either a mixture of ethylene glycol and acetic acid (for oxidations under acidic conditions) or ethylene glycol and water (for oxidations under basic conditions). The results obtained in these experiments confirmed that ethylene glycol acts as a nucleophile in these solvent systems, thereby stabilizing the quinomethide intermediate and resulting in highly efficient oxidations in both alkaline and acidic media. 4-Hydroxybenzaldehyde, the desired product, was thus obtained in isolated yields of up to 98% and purities >99%. The inherent drawbacks associated with alkaline methanol and aqueous acetic acid solutions were thus circumvented, and the result is a highly efficient process for the production of 4-hydroxybenzaidehyde.
    DOI:
    10.1021/op049844j
点击查看最新优质反应信息

文献信息

  • COMPOUND, RESIST COMPOSITION CONTAINING COMPOUND AND PATTERN FORMATION METHOD USING SAME
    申请人:The School Corporation Kansai University
    公开号:US20200057370A1
    公开(公告)日:2020-02-20
    A resist composition comprising one or more tannin compounds selected from the group consisting of a tannin comprising at least one crosslinking reactive group in the structure and a derivative thereof, and a resin obtained using the tannin or the derivative as a monomer.
  • [EN] PROCESS FOR THE PRODUCTION OF HYDROXY-SUBSTITUTED AROMATIC ALDEHYDES AND KETONES<br/>[FR] PROCEDE DE PRODUCTION DE CETONES ET D'ALDEHYDES AROMATIQUES SUBSTITUES PAR HYDROXY
    申请人:DOW AGROSCIENCES LLC
    公开号:WO2001009072A1
    公开(公告)日:2001-02-08
    A method of oxidising an alkylphenol of the formula (I) or (II) to a corresponding hydroxybenzaldehyde or hydroxyacetophenone, wherein: X is CH3 or CH2CH3; each of R1 to R4 is H, Cl, Br, C1-C10 alkyl, or C1-C10 alkoxy; R1 and R2 and R3 or R3 and R4 together may be -(CH2)n-; wherein n is 3 to 6, provided only one of R1 and R2, R2 and R3 or R3 and R4 is -(CH2)n-; includes the steps of producing a reaction medium of the alkylphenol in a solvent which comprises a dihydric alcohol and is acidic or alkaline and reacting the alkylphenol with oxygen in the presence of an oxidation catalyst. Examples of suitable dihydric alcohols are ethylene glycol, 1,2-propanediol, 1,3-propanediol and 1,4-butanediol.
  • Practical Process for the Air Oxidation of Cresols:  Part B. Evaluation of the Laboratory-Scale Oxidation Process
    作者:Benita Barton、Catherine G. Logie、Barbara M. Schoonees、Bernard Zeelie
    DOI:10.1021/op049844j
    日期:2005.1.1
    Mechanistic proposals and predictions made in a preceding paper (Part A) were evaluated by carrying out the catalytic air oxidation of p-cresol in an alternative solvent system, comprising either a mixture of ethylene glycol and acetic acid (for oxidations under acidic conditions) or ethylene glycol and water (for oxidations under basic conditions). The results obtained in these experiments confirmed that ethylene glycol acts as a nucleophile in these solvent systems, thereby stabilizing the quinomethide intermediate and resulting in highly efficient oxidations in both alkaline and acidic media. 4-Hydroxybenzaldehyde, the desired product, was thus obtained in isolated yields of up to 98% and purities >99%. The inherent drawbacks associated with alkaline methanol and aqueous acetic acid solutions were thus circumvented, and the result is a highly efficient process for the production of 4-hydroxybenzaidehyde.
  • Discovery of Thieno[2,3-<i>e</i>]indazole Derivatives as Novel Oral Selective Estrogen Receptor Degraders with Highly Improved Antitumor Effect and Favorable Druggability
    作者:Zhengyu Lu、Yangzhi Cao、Dan Zhang、Xin Meng、Bin Guo、Deyu Kong、Yushe Yang
    DOI:10.1021/acs.jmedchem.2c00008
    日期:2022.4.14
    Endocrine therapies in the treatment of early and metastatic estrogen receptor α positive (ERα+) breast cancer (BC) are greatly limited by de novo and acquired resistance. Selective estrogen receptor degraders (SERDs) like fulvestrant provide new strategies for endocrine therapy combinations due to unique mechanisms. Herein, we disclose our structure-based optimization of LSZ102 by replacing 6-hydroxybenzothiophene
    内分泌治疗在早期和转移性雌激素受体 α 阳性 (ERα+) 乳腺癌 (BC) 的治疗中受到新发耐药和获得性耐药的极大限制。由于独特的机制,选择性雌激素受体降解剂 (SERD) (如氟维司群)为内分泌治疗组合提供了新策略。在此,我们通过用 6 H-噻吩并[2,3 - e ]吲唑代替 6-羟基苯并噻吩,公开了基于结构的 LSZ102 优化。随后的丙烯酸 degron 修饰使我们将化合物40确定为首选候选者。一般来说,化合物40显示出比先导 LSZ102 更好的药理学特征,表现出对野生型或他莫昔芬抗性 MCF-7 细胞的生长抑制,有效的 ERα 降解,以及优越的药代动力学特性,包括大脑在内的定向靶组织分布,以及强大的抗肿瘤功效小鼠乳腺癌异种移植模型。目前,40 个正在临床前试验中进行评估。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐